DocGo Inc.

operator assistance during the conference, please press star then zero on your telephone keypad. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mike Cole, Director of Investor Relations. Please go ahead, sir.

Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements made in this conference call, other than statements of historical fact, are forward-looking statements. The words may, will, plan, potential, could, goal, outlook, design, anticipate, aim, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions may be used to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance, and we cannot assure you that we will achieve or realize our plans, intentions, outcomes, results, or expectations. Forward-looking statements are inherently subject to substantial risks, uncertainties, and assumptions, many of which are beyond our control and which may cause our actual results or outcomes or the timing of results or outcomes to differ materially from those contained in our forward-looking statements. These risks, uncertainties, and assumptions include but are not limited to those discussed in our risk factors and elsewhere in DACA's annual report on Form 10-K, quarterly reports on Form 10-Q, and other reports and statements filed by DACA with the SEC to which your attention is directed. Actual outcomes and results or the timing of results or outcomes may differ materially from what is expressed or implied by these forward-looking statements. In addition, today's call contains references to non-GAAP financial measures. Reconciliations of these non-GAAP financial measures, the most directly comparable GAAP financial measures, are provided directly as part of this call or included in our earnings release, which is posted on our website, DACA.gov. as well as filed with the Securities and Exchange Commission. The information contained in this call is accurate as of only the date discussed. Investors should not assume that statements will remain relevant and operative at a later time. We undertake no obligation to update any information discussed in this call to reflect events or circumstances after the date of this call or to reflect new information or the occurrence of unanticipated events, except as to the extent required by law. At this time, it is now my pleasure to turn the call over to Mr. Lee Beanstalk, CEO of DOTCO. Lee, please go ahead.

Thank you, Mike, and thank you all for joining today. I'm extremely pleased with our Q1 performance and our operational execution on all fronts. We are making considerable progress expanding our care gap closure programs with major insurance companies. We're proud of the diverse set of population health services we're providing underserved communities. and our medical transportation business with hospital systems remains strong and is growing nicely. We recorded 192.1 million in revenue, had record adjusted EBITDA of 24.1 million. We served a record number of medical transportation patients, launched our primary care offering, introduced a new mobile x-ray program, and continued to hire top talent for our leadership team in Q1. To start, I would like to discuss our updated guidance for 2024. On our last earnings call, we provided guidance for 2024 with expected annual revenues in a range of $720 to $750 million and adjusted EBITDA of $80 to $85 million. Given the accelerated timing of the wind down of migrant related projects and associated revenues, we are updating our revenue and adjusted EBITDA guidance. We now anticipate full year 2024 revenues of $600 to $650 million. This includes migrant-related revenues of approximately $320 to $350 million, and revenues from our base business lines going forward, our medical transportation business and our non-migrant mobile health business, of $280 to $300 million. This reduction in guidance comes solely from the accelerated wind down of certain migrant services projects. The base business performed at expected levels in Q1 and should track in line with original guidance throughout the year. Breaking this base revenue down further, we expect non-migrant mobile health revenues of approximately 105 million and transportation revenues of 195 million at the high end of the range. We now see adjusted EBITDA for the full year in a range of 65 to 75 million, representing an 11% adjusted EBITDA margin. We have embarked upon a program to optimize our operating expenses so that we can maintain adjusted EBITDA margins as the migrant-related revenues wind down. I would also like to provide some color beyond 2024. Looking ahead to 2025, we plan to grow our base revenue from 280 to 300 million to 400 million and expect 50 million in adjusted EBITDA. We anticipate that 400 million in revenue to break down as follows. Roughly 175 million in non-migrant mobile health and 225 million in transportation. Breaking it down by customer vertical, we expect 250 million from hospital system customers, 100 million from municipal customers, and 50 million from payer and provider programs. While it is possible that some of the current migrant-related projects could carry over into 2025, any migrant revenues in 2025 would be incremental to this base amount. Our 2025 base revenue goal would represent an increase of over 30% from 2024, and as usual, I'd love to share some drivers from our three customer verticals that are helping support this growth. First, our work with insurance companies continues to accelerate, and we now have CareGap closure-focused contracts with two out of the five largest health insurance companies in the country. We are actively planning expansions with payers in California and New York, with more in the pipeline. We have an innovative model that engages health plan members to address gaps in care with convenient home visits and provide ongoing care for those lacking access to a traditional primary care provider. In fact, we're excited to announce that this past quarter, DACO has launched its mobile and virtual PCP offering to better meet the needs of the patients we see every day. And we are working to bring this new offering to more patients through our health plan partnerships. We believe that by serving as the patient's PCP with our unique in-home and virtual model, we can help better coordinate their care and improve health outcomes. We're excited about what our innovative approach to primary care can do for our patients. For example, one of our first PCP patients was discharged from a rehab center in December and needed cataract surgery, but was recovering from a stroke at home and lacked a relationship with a PCP who could provide a clearance exam for her surgery. We deployed our combined virtual and in-home PCP offering to provide her with a full exam including labs and an EKG. After we completed all the necessary testing, we followed up in her home again and cleared her for her overdue eye surgery. This was a procedure she desperately needed to improve her quality of life and it wouldn't have been possible without our visits. We now have a total of eight different payer contracts in place, allowing us to leverage our mobile capabilities to provide greater access to healthcare for traditionally hard to reach populations and providing a platform for future revenue growth. We also continue to make progress with our remote monitoring and virtual care management offerings. We have signed new patient monitoring contracts with two large cardiology practices in Ohio and Delaware and launched two new virtual care programs in New Jersey and Pennsylvania. To give a sense and an example of how we scale this business, last year, a 3 million member health plan contracted with Doc O to see members across multiple states and lines of business, including their Medicare, Medicaid, and commercial exchange health plans. They assigned Doc O around 25,000 members with known gaps in care, including no recent hemoglobin A1C or blood pressure tests, overdue diabetic eye exams, kidney health evaluations, and bone density screenings. In less than five months, we saw over 1,400 members with in-home and virtual visits and helped improve quality metrics by closing over 3,500 heated STARS-related care gaps. Based on these results, the health plan is expanding the number of patients it's assigning .go by 50% in 2024. Our goal to scale our insurance and patient monitoring business for 2025 is to complete over 65,000 care gap closures, to enroll 10,000 PCP patients, and monitor over 70,000 patients. These metrics are all in line with our current partnerships and pipeline of future partners. Second, our transportation service vertical saw record trip volumes in Q1, in part due to our large health system partners in the US and the UK experiencing higher patient volumes. We pride ourselves on being able to support capacity management efforts by collaborating closely with our hospital partners. Concurrently, we have fully deployed our Leased Hour program with Mainline Health in Pennsylvania. We've been awarded a Leased Hour 9-1-1 contract in Dover, Delaware, and have launched medical transportation at Lettix Hill Hospital in Manhattan. We continue to grow our event medical services, including a new contract with Ballpark Commons in Wisconsin and our work with New York City Football Club. In addition, we are increasingly expanding our mobile health footprint within this customer base. While mobile health services are still a relatively small component of the equation today, they have the potential to grow substantially over time, given our ability to help our customers keep lower acuity patients out of the emergency room, which is exactly what our health system customers want. And third, within our municipal population health business, we debuted an exciting new mobile x-ray program which we expect will initially be used to help diagnose tuberculosis in underserved populations, but we believe has much broader utility beyond that. We introduced our first mobile x-ray unit at the National Tuberculosis Coalition of America's annual TB conference in Baltimore, Maryland, and believe this program has considerable growth potential in the near term, as many geographies across the country are experiencing a sharp increase in cases of TB. We're already seeing strong municipal interest in this offering, and look forward to sharing additional updates as this program expands. Going forward, our growth will be driven by our pipeline of municipal RFPs for larger, more sustainable behavioral health and population health programs. The noise surrounding our market-related work wound up clouding the core story of DACO. My job is to remind everybody what that story is. We have built our proprietary technology platform to efficiently and profitably deploy thousands of clinicians and hundreds of mobile units daily to bring care to patients wherever they may be. In a post-pandemic world that is coming to the realization that telehealth alone is insufficient to truly impact patient outcomes, Our combination of technology and caring hands on clinical services allows us to do what telehealth alone cannot. We're able to meet patients on their terms, in person, expanding access and helping keep people out of the hospital, which at the end of the day is what everyone wants. We've created a differentiated model, a differentiated product, and a differentiated patient experience. There is a tremendous market, a world of partners, and millions of patients that need us. With that, I'll hand it over to Norm to cover the financials.